Growth Metrics

Acadia Pharmaceuticals (ACAD) Assets Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Acadia Pharmaceuticals 3.69 Bn 2.84 Bn 243.27 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 34.80%
Dec 31, 2025 38.57%
Sep 30, 2025 30.23%
Jun 30, 2025 25.99%
Mar 31, 2025 21.96%
Dec 31, 2024 19.27%
Sep 30, 2024 10.82%
Jun 30, 2024 8.06%
Mar 31, 2024 4.23%
Dec 31, 2023 -1.45%
Sep 30, 2023 -7.36%
Jun 30, 2023 -5.42%
Mar 31, 2023 -4.29%
Dec 31, 2022 -9.12%
Sep 30, 2022 -7.68%
Jun 30, 2022 9.96%
Mar 31, 2022 7.60%
Dec 31, 2021 9.03%
Sep 30, 2021 39.13%
Jun 30, 2021 32.00%
Mar 31, 2021 29.09%
Dec 31, 2020 26.73%
Sep 30, 2020 24.36%
Jun 30, 2020 18.52%
Mar 31, 2020 14.11%
Dec 31, 2019 11.75%
Sep 30, 2019 7.44%
Jun 30, 2019 1.71%
Mar 31, 2019 2.41%
Dec 31, 2018 34.52%
Sep 30, 2018 2.79%
Jun 30, 2018 4.56%
Mar 31, 2018 5.15%
Dec 31, 2017 5.71%
Sep 30, 2017 6.58%
Jun 30, 2017 8.28%
Mar 31, 2017 10.43%
Dec 31, 2016 43.70%
Sep 30, 2016 45.78%
Jun 30, 2016 28.40%
Mar 31, 2016 65.45%
Dec 31, 2015 26.90%
Sep 30, 2015 117.78%
Jun 30, 2015 132.68%
Mar 31, 2015 124.97%
Dec 31, 2014 116.40%
Sep 30, 2014 109.78%
Jun 30, 2014 105.69%
Dec 31, 2013 70.15%